AbbVie (ABBV)
(Delayed Data from NYSE)
$161.24 USD
+4.93 (3.15%)
Updated May 31, 2024 04:05 PM ET
After-Market: $160.69 -0.55 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/25/2024
Time: -- |
6/2024 | $3.05 | -0.37% |
Earnings Summary
For their last quarter, AbbVie (ABBV) reported earnings of $2.31 per share, beating the Zacks Consensus Estimate of $2.26 per share. This reflects a positive earnings surprise of 2.21%. Look out for ABBV's next earnings release expected on July 25, 2024. For the next earning release, we expect the company to report earnings of $3.05 per share, reflecting a year-over-year increase of 4.81%.
Earnings History
Price & Consensus
Zacks News for ABBV
Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?
ABBV: What are Zacks experts saying now?
Zacks Private Portfolio Services